KALA:NASDAQ, KALA BIO, Inc.

Why KALA stock fell on November 13

KALA BIO, Inc. fell 13.7% on Friday, November 13, 2026, on 935,000 shares, 18 times its average daily volume. The headline around the move:

KALA stock overview

KALA BIO, Inc. (KALA:NASDAQ) closed at $3.83 on November 16, 2026, down 8.02% on the day. The stock trades 99.9% below its 52-week high of $2,865.00 and 11.4% above its 52-week low of $3.44. Over the past year, it lost 89.0%. KALA BIO, Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$3.83
Day change
-8.02%
Volume
29,217
Average volume
51,415
Market cap
2M+
52-week range
$3.44 – $2,865.00
50-day average
$9.97
200-day average
$144.01

Price action over the past year

In 251 trading sessions since November 14, 2025, KALA closed higher on 95 days (38%). Its best day was November 26, 2025 (+42.63%) and its worst was May 7, 2026 (-27.83%). The stock moved 10% or more in a single session 49 times. It opened at least 5% above the previous day's high 6 times.

Recent signals

KALA news

About KALA BIO, Inc.

Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles technology, with focus on the treatment of eye diseases.

Similar stocks

Find more stocks like KALA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.